![Raymond Deshaies](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Raymond Deshaies
Direktör/Styrelseledamot på
XENCOR, INC.
Förmögenhet: 208 203 $ per 2026-07-31
Profil
Raymond J.
Deshaies is the founder of Cleave Therapeutics, Inc., founded in 2010.
Dr. Deshaies is also the founder of Proteolix, Inc. Dr. Deshaies is an Independent Director at Xencor, Inc. starting in 2025.
Former positions include Investigator at Howard Hughes Medical Institute, Inc., Senior Vice President-Global Research at Amgen, Inc. from 2017 to 2025, and Executive Officer & Professor at California Institute of Technology.
Education includes undergraduate studies at Cornell University and a doctorate from the University of California, Berkeley.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
XENCOR, INC. 0,01 % | 2026-06-16 | 10 302 ( 0,01 % ) | 208 203 $ | 2026-07-31 |
Aktiva positioner av Raymond Deshaies
| Företag | Position | Start |
|---|---|---|
| XENCOR, INC. | Direktör/Styrelseledamot | 2025-07-31 |
Tidigare kända positioner av Raymond Deshaies
| Företag | Position | Slut |
|---|---|---|
| AMGEN INC. | Företagsledare/Principal | 2025-06-01 |
Proteolix, Inc.
 Proteolix, Inc. Pharmaceuticals: MajorHealth Technology Manufactures bio-pharmaceutical related products | Grundare | 2009-10-01 |
California Institute of Technology
 California Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Företagsledare/Principal | - |
Howard Hughes Medical Institute, Inc.
 Howard Hughes Medical Institute, Inc. Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Företagsledare/Principal | - |
Cleave Therapeutics, Inc.
 Cleave Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops medicine for oncology and neurodegeneration treatment | Grundare | - |
Raymond Deshaiess utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
78
Första gradens relationer
8
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 8 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Xencor, Inc.
 Xencor, Inc. BiotechnologyHealth Technology Develops therapeutics to treat autoimmune and allergic diseases, cancer and other conditions | Health Technology |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
California Institute of Technology
California Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Howard Hughes Medical Institute, Inc.
Howard Hughes Medical Institute, Inc. Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Proteolix, Inc.
Proteolix, Inc. Pharmaceuticals: MajorHealth Technology Manufactures bio-pharmaceutical related products | Health Technology |
Cleave Therapeutics, Inc.
Cleave Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops medicine for oncology and neurodegeneration treatment | Health Technology |
